|

Gedatolisib Clinical Trials

2 actively recruiting trials across 2 locations

Also known as: PF-05212384

Pipeline

Phase 2: 1Phase 1/2: 1

Top Sponsors

  • Dana-Farber Cancer Institute1
  • Celcuity Inc1

Indications

  • Cancer2
  • Prostatic Disease1
  • Genital Diseases, Male1
  • Urogenital Diseases, Male1
  • Prostatic Neoplasms, Castration-Resistant1

Boston, Massachusetts1 trial

RESOLVE: Abemaciclib + Letrozole +/- Metformin, Zotatifin, or Gedatolisib in Endometrial or Low-Grade Serous Ovarian Cancer

Massachusetts General Hospital Cancer Center

Phase 2

Detroit, Michigan1 trial

Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer

Barbara Ann Karmanos Cancer Institute

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.